 | • レポートコード：MRC2-11QY04597 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は性感染症（STD）診断のグローバル市場について調査・分析したレポートです。種類別（クラミジア検査、梅毒検査、淋病検査、単純ヘルペスウイルス検査、ヒトパピローマウイルス検査、ヒト免疫不全ウイルス検査）市場規模、用途別（政府機関、病院、診断クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別性感染症（STD）診断の競争状況、市場シェア ・世界の性感染症（STD）診断市場：種類別市場規模 2015年-2020年（クラミジア検査、梅毒検査、淋病検査、単純ヘルペスウイルス検査、ヒトパピローマウイルス検査、ヒト免疫不全ウイルス検査） ・世界の性感染症（STD）診断市場：種類別市場規模予測 2021年-2026年（クラミジア検査、梅毒検査、淋病検査、単純ヘルペスウイルス検査、ヒトパピローマウイルス検査、ヒト免疫不全ウイルス検査） ・世界の性感染症（STD）診断市場：用途別市場規模 2015年-2020年（政府機関、病院、診断クリニック） ・世界の性感染症（STD）診断市場：用途別市場規模予測 2021年-2026年（政府機関、病院、診断クリニック） ・北米の性感染症（STD）診断市場分析：米国、カナダ ・ヨーロッパの性感染症（STD）診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの性感染症（STD）診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の性感染症（STD）診断市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの性感染症（STD）診断市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott、Roche、Thermo Fisher Scientific、Aposcience、BCR Diagnostics、BD Medical、Biocartis、BioMérieux、Bio-Rad、Cepheid、Danaher、DiaSorin、Quidel、GenMark Diagnostics、Hologic、OraSure Technologies、Qualigen ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Sexually transmitted diseases (STDs) are infections that are passed from one person to another through sexual contact. The causes of STDs are bacteria, parasites, yeast, and viruses.
Sexually Transmitted Disease is growing at a faster pace owing to the rising incidences of unprotected sex, lack of awareness and so forth. The rising number of patients suffering from STD includes people from age group of 15 years to 24 years.
Market Analysis and Insights: Global Sexually Transmitted Disease (STD) Diagnosis Market
The global Sexually Transmitted Disease (STD) Diagnosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Sexually Transmitted Disease (STD) Diagnosis Scope and Market Size
Sexually Transmitted Disease (STD) Diagnosis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sexually Transmitted Disease (STD) Diagnosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott
Roche
Thermo Fisher Scientific
Aposcience
BCR Diagnostics
BD Medical
Biocartis
BioMérieux
Bio-Rad
Cepheid
Danaher
DiaSorin
Quidel
GenMark Diagnostics
Hologic
OraSure Technologies
Qualigen
Market segment by Type, the product can be split into
Chlamydia testing
Syphilis testing
Gonorrhoea testing
Herpes simplex virus testing
Human papilloma virus testing
Human immunodeficiency virus testing
Market segment by Application, split into
Government organizations
Hospitals
Diagnostic clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Sexually Transmitted Disease (STD) Diagnosis Revenue
1.4 Market by Type
1.4.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chlamydia testing
1.4.3 Syphilis testing
1.4.4 Gonorrhoea testing
1.4.5 Herpes simplex virus testing
1.4.6 Human papilloma virus testing
1.4.7 Human immunodeficiency virus testing
1.5 Market by Application
1.5.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Application: 2020 VS 2026
1.5.2 Government organizations
1.5.3 Hospitals
1.5.4 Diagnostic clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Perspective (2015-2026)
2.2 Global Sexually Transmitted Disease (STD) Diagnosis Growth Trends by Regions
2.2.1 Sexually Transmitted Disease (STD) Diagnosis Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Sexually Transmitted Disease (STD) Diagnosis Historic Market Share by Regions (2015-2020)
2.2.3 Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Sexually Transmitted Disease (STD) Diagnosis Market Growth Strategy
2.3.6 Primary Interviews with Key Sexually Transmitted Disease (STD) Diagnosis Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Market Size
3.1.1 Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Revenue (2015-2020)
3.1.2 Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Players (2015-2020)
3.1.3 Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Concentration Ratio
3.2.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Disease (STD) Diagnosis Revenue in 2019
3.3 Sexually Transmitted Disease (STD) Diagnosis Key Players Head office and Area Served
3.4 Key Players Sexually Transmitted Disease (STD) Diagnosis Product Solution and Service
3.5 Date of Enter into Sexually Transmitted Disease (STD) Diagnosis Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Sexually Transmitted Disease (STD) Diagnosis Historic Market Size by Type (2015-2020)
4.2 Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020)
5.2 Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Sexually Transmitted Disease (STD) Diagnosis Market Size (2015-2020)
6.2 Sexually Transmitted Disease (STD) Diagnosis Key Players in North America (2019-2020)
6.3 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020)
6.4 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020)
7 Europe
7.1 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size (2015-2020)
7.2 Sexually Transmitted Disease (STD) Diagnosis Key Players in Europe (2019-2020)
7.3 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020)
7.4 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020)
8 China
8.1 China Sexually Transmitted Disease (STD) Diagnosis Market Size (2015-2020)
8.2 Sexually Transmitted Disease (STD) Diagnosis Key Players in China (2019-2020)
8.3 China Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020)
8.4 China Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020)
9 Japan
9.1 Japan Sexually Transmitted Disease (STD) Diagnosis Market Size (2015-2020)
9.2 Sexually Transmitted Disease (STD) Diagnosis Key Players in Japan (2019-2020)
9.3 Japan Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020)
9.4 Japan Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Size (2015-2020)
10.2 Sexually Transmitted Disease (STD) Diagnosis Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020)
10.4 Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020)
11 India
11.1 India Sexually Transmitted Disease (STD) Diagnosis Market Size (2015-2020)
11.2 Sexually Transmitted Disease (STD) Diagnosis Key Players in India (2019-2020)
11.3 India Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020)
11.4 India Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Sexually Transmitted Disease (STD) Diagnosis Market Size (2015-2020)
12.2 Sexually Transmitted Disease (STD) Diagnosis Key Players in Central & South America (2019-2020)
12.3 Central & South America Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020)
12.4 Central & South America Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott Sexually Transmitted Disease (STD) Diagnosis Introduction
13.1.4 Abbott Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview
13.2.3 Roche Sexually Transmitted Disease (STD) Diagnosis Introduction
13.2.4 Roche Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
13.2.5 Roche Recent Development
13.3 Thermo Fisher Scientific
13.3.1 Thermo Fisher Scientific Company Details
13.3.2 Thermo Fisher Scientific Business Overview
13.3.3 Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Introduction
13.3.4 Thermo Fisher Scientific Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
13.3.5 Thermo Fisher Scientific Recent Development
13.4 Aposcience
13.4.1 Aposcience Company Details
13.4.2 Aposcience Business Overview
13.4.3 Aposcience Sexually Transmitted Disease (STD) Diagnosis Introduction
13.4.4 Aposcience Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
13.4.5 Aposcience Recent Development
13.5 BCR Diagnostics
13.5.1 BCR Diagnostics Company Details
13.5.2 BCR Diagnostics Business Overview
13.5.3 BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Introduction
13.5.4 BCR Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
13.5.5 BCR Diagnostics Recent Development
13.6 BD Medical
13.6.1 BD Medical Company Details
13.6.2 BD Medical Business Overview
13.6.3 BD Medical Sexually Transmitted Disease (STD) Diagnosis Introduction
13.6.4 BD Medical Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
13.6.5 BD Medical Recent Development
13.7 Biocartis
13.7.1 Biocartis Company Details
13.7.2 Biocartis Business Overview
13.7.3 Biocartis Sexually Transmitted Disease (STD) Diagnosis Introduction
13.7.4 Biocartis Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
13.7.5 Biocartis Recent Development
13.8 BioMérieux
13.8.1 BioMérieux Company Details
13.8.2 BioMérieux Business Overview
13.8.3 BioMérieux Sexually Transmitted Disease (STD) Diagnosis Introduction
13.8.4 BioMérieux Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
13.8.5 BioMérieux Recent Development
13.9 Bio-Rad
13.9.1 Bio-Rad Company Details
13.9.2 Bio-Rad Business Overview
13.9.3 Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Introduction
13.9.4 Bio-Rad Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
13.9.5 Bio-Rad Recent Development
13.10 Cepheid
13.10.1 Cepheid Company Details
13.10.2 Cepheid Business Overview
13.10.3 Cepheid Sexually Transmitted Disease (STD) Diagnosis Introduction
13.10.4 Cepheid Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
13.10.5 Cepheid Recent Development
13.11 Danaher
10.11.1 Danaher Company Details
10.11.2 Danaher Business Overview
10.11.3 Danaher Sexually Transmitted Disease (STD) Diagnosis Introduction
10.11.4 Danaher Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
10.11.5 Danaher Recent Development
13.12 DiaSorin
10.12.1 DiaSorin Company Details
10.12.2 DiaSorin Business Overview
10.12.3 DiaSorin Sexually Transmitted Disease (STD) Diagnosis Introduction
10.12.4 DiaSorin Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
10.12.5 DiaSorin Recent Development
13.13 Quidel
10.13.1 Quidel Company Details
10.13.2 Quidel Business Overview
10.13.3 Quidel Sexually Transmitted Disease (STD) Diagnosis Introduction
10.13.4 Quidel Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
10.13.5 Quidel Recent Development
13.14 GenMark Diagnostics
10.14.1 GenMark Diagnostics Company Details
10.14.2 GenMark Diagnostics Business Overview
10.14.3 GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Introduction
10.14.4 GenMark Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
10.14.5 GenMark Diagnostics Recent Development
13.15 Hologic
10.15.1 Hologic Company Details
10.15.2 Hologic Business Overview
10.15.3 Hologic Sexually Transmitted Disease (STD) Diagnosis Introduction
10.15.4 Hologic Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
10.15.5 Hologic Recent Development
13.16 OraSure Technologies
10.16.1 OraSure Technologies Company Details
10.16.2 OraSure Technologies Business Overview
10.16.3 OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Introduction
10.16.4 OraSure Technologies Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
10.16.5 OraSure Technologies Recent Development
13.17 Qualigen
10.17.1 Qualigen Company Details
10.17.2 Qualigen Business Overview
10.17.3 Qualigen Sexually Transmitted Disease (STD) Diagnosis Introduction
10.17.4 Qualigen Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
10.17.5 Qualigen Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Sexually Transmitted Disease (STD) Diagnosis Key Market Segments
Table 2. Key Players Covered: Ranking by Sexually Transmitted Disease (STD) Diagnosis Revenue
Table 3. Ranking of Global Top Sexually Transmitted Disease (STD) Diagnosis Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chlamydia testing
Table 6. Key Players of Syphilis testing
Table 7. Key Players of Gonorrhoea testing
Table 8. Key Players of Herpes simplex virus testing
Table 9. Key Players of Human papilloma virus testing
Table 10. Key Players of Human immunodeficiency virus testing
Table 11. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Regions (2015-2020)
Table 15. Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Sexually Transmitted Disease (STD) Diagnosis Market Growth Strategy
Table 21. Main Points Interviewed from Key Sexually Transmitted Disease (STD) Diagnosis Players
Table 22. Global Sexually Transmitted Disease (STD) Diagnosis Revenue by Players (2015-2020) (Million US$)
Table 23. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Players (2015-2020)
Table 24. Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sexually Transmitted Disease (STD) Diagnosis as of 2019)
Table 25. Global Sexually Transmitted Disease (STD) Diagnosis by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Sexually Transmitted Disease (STD) Diagnosis Product Solution and Service
Table 28. Date of Enter into Sexually Transmitted Disease (STD) Diagnosis Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020) (Million US$)
Table 31. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Share by Type (2015-2020)
Table 32. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Type (2021-2026)
Table 33. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Share by Application (2015-2020)
Table 34. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020) (Million US$)
Table 35. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Share by Application (2021-2026)
Table 36. North America Key Players Sexually Transmitted Disease (STD) Diagnosis Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Sexually Transmitted Disease (STD) Diagnosis Market Share (2019-2020)
Table 38. North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020) (Million US$)
Table 39. North America Sexually Transmitted Disease (STD) Diagnosis Market Share by Type (2015-2020)
Table 40. North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020) (Million US$)
Table 41. North America Sexually Transmitted Disease (STD) Diagnosis Market Share by Application (2015-2020)
Table 42. Europe Key Players Sexually Transmitted Disease (STD) Diagnosis Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Sexually Transmitted Disease (STD) Diagnosis Market Share (2019-2020)
Table 44. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Sexually Transmitted Disease (STD) Diagnosis Market Share by Type (2015-2020)
Table 46. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Sexually Transmitted Disease (STD) Diagnosis Market Share by Application (2015-2020)
Table 48. China Key Players Sexually Transmitted Disease (STD) Diagnosis Revenue (2019-2020) (Million US$)
Table 49. China Key Players Sexually Transmitted Disease (STD) Diagnosis Market Share (2019-2020)
Table 50. China Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020) (Million US$)
Table 51. China Sexually Transmitted Disease (STD) Diagnosis Market Share by Type (2015-2020)
Table 52. China Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020) (Million US$)
Table 53. China Sexually Transmitted Disease (STD) Diagnosis Market Share by Application (2015-2020)
Table 54. Japan Key Players Sexually Transmitted Disease (STD) Diagnosis Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Sexually Transmitted Disease (STD) Diagnosis Market Share (2019-2020)
Table 56. Japan Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Sexually Transmitted Disease (STD) Diagnosis Market Share by Type (2015-2020)
Table 58. Japan Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Sexually Transmitted Disease (STD) Diagnosis Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Sexually Transmitted Disease (STD) Diagnosis Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Sexually Transmitted Disease (STD) Diagnosis Market Share (2019-2020)
Table 62. Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Share by Type (2015-2020)
Table 64. Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Share by Application (2015-2020)
Table 66. India Key Players Sexually Transmitted Disease (STD) Diagnosis Revenue (2019-2020) (Million US$)
Table 67. India Key Players Sexually Transmitted Disease (STD) Diagnosis Market Share (2019-2020)
Table 68. India Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020) (Million US$)
Table 69. India Sexually Transmitted Disease (STD) Diagnosis Market Share by Type (2015-2020)
Table 70. India Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020) (Million US$)
Table 71. India Sexually Transmitted Disease (STD) Diagnosis Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Sexually Transmitted Disease (STD) Diagnosis Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Sexually Transmitted Disease (STD) Diagnosis Market Share (2019-2020)
Table 74. Central & South America Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Sexually Transmitted Disease (STD) Diagnosis Market Share by Type (2015-2020)
Table 76. Central & South America Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Sexually Transmitted Disease (STD) Diagnosis Market Share by Application (2015-2020)
Table 78. Abbott Company Details
Table 79. Abbott Business Overview
Table 80. Abbott Product
Table 81. Abbott Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020) (Million US$)
Table 82. Abbott Recent Development
Table 83. Roche Company Details
Table 84. Roche Business Overview
Table 85. Roche Product
Table 86. Roche Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020) (Million US$)
Table 87. Roche Recent Development
Table 88. Thermo Fisher Scientific Company Details
Table 89. Thermo Fisher Scientific Business Overview
Table 90. Thermo Fisher Scientific Product
Table 91. Thermo Fisher Scientific Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020) (Million US$)
Table 92. Thermo Fisher Scientific Recent Development
Table 93. Aposcience Company Details
Table 94. Aposcience Business Overview
Table 95. Aposcience Product
Table 96. Aposcience Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020) (Million US$)
Table 97. Aposcience Recent Development
Table 98. BCR Diagnostics Company Details
Table 99. BCR Diagnostics Business Overview
Table 100. BCR Diagnostics Product
Table 101. BCR Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020) (Million US$)
Table 102. BCR Diagnostics Recent Development
Table 103. BD Medical Company Details
Table 104. BD Medical Business Overview
Table 105. BD Medical Product
Table 106. BD Medical Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020) (Million US$)
Table 107. BD Medical Recent Development
Table 108. Biocartis Company Details
Table 109. Biocartis Business Overview
Table 110. Biocartis Product
Table 111. Biocartis Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020) (Million US$)
Table 112. Biocartis Recent Development
Table 113. BioMérieux Business Overview
Table 114. BioMérieux Product
Table 115. BioMérieux Company Details
Table 116. BioMérieux Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020) (Million US$)
Table 117. BioMérieux Recent Development
Table 118. Bio-Rad Company Details
Table 119. Bio-Rad Business Overview
Table 120. Bio-Rad Product
Table 121. Bio-Rad Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020) (Million US$)
Table 122. Bio-Rad Recent Development
Table 123. Cepheid Company Details
Table 124. Cepheid Business Overview
Table 125. Cepheid Product
Table 126. Cepheid Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020) (Million US$)
Table 127. Cepheid Recent Development
Table 128. Danaher Company Details
Table 129. Danaher Business Overview
Table 130. Danaher Product
Table 131. Danaher Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020) (Million US$)
Table 132. Danaher Recent Development
Table 133. DiaSorin Company Details
Table 134. DiaSorin Business Overview
Table 135. DiaSorin Product
Table 136. DiaSorin Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020) (Million US$)
Table 137. DiaSorin Recent Development
Table 138. Quidel Company Details
Table 139. Quidel Business Overview
Table 140. Quidel Product
Table 141. Quidel Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020) (Million US$)
Table 142. Quidel Recent Development
Table 143. GenMark Diagnostics Company Details
Table 144. GenMark Diagnostics Business Overview
Table 145. GenMark Diagnostics Product
Table 146. GenMark Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020) (Million US$)
Table 147. GenMark Diagnostics Recent Development
Table 148. Hologic Company Details
Table 149. Hologic Business Overview
Table 150. Hologic Product
Table 151. Hologic Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020) (Million US$)
Table 152. Hologic Recent Development
Table 153. OraSure Technologies Company Details
Table 154. OraSure Technologies Business Overview
Table 155. OraSure Technologies Product
Table 156. OraSure Technologies Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020) (Million US$)
Table 157. OraSure Technologies Recent Development
Table 158. Qualigen Company Details
Table 159. Qualigen Business Overview
Table 160. Qualigen Product
Table 161. Qualigen Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020) (Million US$)
Table 162. Qualigen Recent Development
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Type: 2020 VS 2026
Figure 2. Chlamydia testing Features
Figure 3. Syphilis testing Features
Figure 4. Gonorrhoea testing Features
Figure 5. Herpes simplex virus testing Features
Figure 6. Human papilloma virus testing Features
Figure 7. Human immunodeficiency virus testing Features
Figure 8. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Application: 2020 VS 2026
Figure 9. Government organizations Case Studies
Figure 10. Hospitals Case Studies
Figure 11. Diagnostic clinics Case Studies
Figure 12. Sexually Transmitted Disease (STD) Diagnosis Report Years Considered
Figure 13. Global Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Regions: 2020 VS 2026
Figure 15. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Players in 2019
Figure 18. Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sexually Transmitted Disease (STD) Diagnosis as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Sexually Transmitted Disease (STD) Diagnosis Revenue in 2019
Figure 20. North America Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
ヒトパピローマウイルス（HPV）検査の世界市場（～2026年） HPV testing and Pap test market has been divided into two major segments on basis of test type, namely, HPV testing and Pap test. The increasing incidence rate of cervical and vaginal cancer is the key driver for the market growth. Market Analysis and Insights: Global Human papilloma virus Testing M…- 流行性耳下腺炎ウイルス検査の世界市場（～2026年） Mumps is a contagious disease which affects children as well as adult and it is caused by the mumps virus. Mumps is a type of viral infection that affects the parotid gland which one of the member of saliva producing gland. The swelling in one or both parotid gland is the indication for the mumps. T…
- 血液ウイルス検査の世界市場（～2026年） Viral testing is carried out to detect infections caused by viruses by destroying cells of immune system. Viruses breed only in living cells and cause diseases by destructing or injuring the cells they infect, damaging the body's whole immune system, altering the genetic material (DNA) of the cells …
- 性感染症（STD）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Sexually Transmitted Disease (STD ) Drug Market The global Sexually Transmitted Disease (STD ) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Sexually Transmitted Disease (STD…
- ヒト免疫不全ウイルス（HIV）の世界市場（～2026年） HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in the body and makes the immune system vulnerable to life-threatening infections and cancers. An infected person c…